PEMDOTLS: Preclinical evaluation of Miltefosin derivatives optimised for the treatment of Leishmaniasis and Sleep Disease. (Q2906826): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Import item from Portugal) |
(Changed an Item) |
||||||||||||||
Property / thematic objective | |||||||||||||||
Property / thematic objective: Research and innovation / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / date of last update | |||||||||||||||
23 May 2023
| |||||||||||||||
Property / date of last update: 23 May 2023 / rank | |||||||||||||||
Normal rank |
Revision as of 19:16, 23 May 2023
Project Q2906826 in Portugal
Language | Label | Description | Also known as |
---|---|---|---|
English | PEMDOTLS: Preclinical evaluation of Miltefosin derivatives optimised for the treatment of Leishmaniasis and Sleep Disease. |
Project Q2906826 in Portugal |
Statements
204,000.0 Euro
0 references
240,000.0 Euro
0 references
85.0 percent
0 references
26 July 2018
0 references
25 July 2022
0 references
INSTITUTO DE BIOLOGIA MOLECULAR E CELULAR - IBMC
0 references
Q2985732 (Deleted Item)
0 references
Porto
0 references
23 May 2023
0 references
Identifiers
POCI-01-0145-FEDER-031013
0 references